Differential effect of metabolic inhibitors on myogenic tone and contractility in isolated tibial arteries.
D000255:Adenosine Triphosphate / Q000032:analysis; D000818:Animals; D001158:Arteries / Q000032:analysis / Q000187:drug effects* / Q000378:metabolism; D001386:Azides / Q000494:pharmacology; D001464:Barium / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002132:Calcium Radioisotopes; D004396:Coloring Agents / Q000494:pharmacology*; D003486:Cyanides / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005463:Fluoroacetates / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009129:Muscle Tonus / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D009638:Norepinephrine / Q000494:pharmacology; D012428:Ruthenium / Q000494:pharmacology; D013977:Tibia / Q000098:blood supply* / Q000187:drug effects
D001386:Azides; D002132:Calcium Radioisotopes; D004396:Coloring Agents; D003486:Cyanides; D004140:Dinitrophenols; D005463:Fluoroacetates; D001464:Barium; D012428:Ruthenium; D000255:Adenosine Triphosphate; D002118:Calcium; D009638:Norepinephrine